Percheron Therapeutics Limited Stock: price and insider trades · Australia

Percheron Therapeutics Limited belongs to the Health Care sector. Filings by its managers are published through ASX. 3 insiders have disclosed 7 filings since 6 November 2025.

The record shows 3 purchases on the open market worth €62k, made by 1 insider, against 1 sale by 1 insider. No amount is published for 3 filings, which the totals therefore leave out. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The largest single trade was a purchase of €62k by Michael Baker, published on 14 October 2026, equal to 1.8% of the market capitalisation. On the buying side, the filings list 1 senior executive among the declarants.

With 7 filings in twelve months, the company is more active than the median of 5 filings across the 1,626 companies we follow on the same exchange. Looking back to 2026, when coverage begins, insiders filed 3 purchases and 1 sale.

The last insider purchase was made public on 6 November 2026, 3 days ago. The median gap between trade and publication is zero days: most filings appear on the same day. Until a filing is published, the market cannot know about the trade.

In the same sector, recent insider purchases at Dynavox Group AB and Vetoquinol SA also feature in our signals. This summary is built from ASX disclosures alone and does not predict where the share price will go.